未登录
分享
收藏
分享
收藏ASO Visual Abstract: Prognostic Impact of Sarcopenia and Surgical Timing in Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy-TIMES Study
Huang, Guiyu; Zhu, Jie; He, Bingrong; Zhou, Xiaoding; Wang, Yi; Wu, Lei; Zhang, Wencheng; Huang, Wei; Hu, Bing; Zheng, Zhunhao; Wan, Gang; Li, Na; Leng, Xuefeng; Han, Yongtao; Peng, Lin; Tang, Xiaoli; Wang, Qifeng
分享
收藏
分享
收藏Prognostic Impact of Sarcopenia and Surgical Timing in Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy: TIMES Study
Huang, Guiyu; Zhu, Jie; He, Bingrong; Zhou, Xiaoding; Wang, Yi; Wu, Lei; Zhang, Wencheng; Huang, Wei; Hu, Bing; Zheng, Zhunhao; Wan, Gang; Li, Na; Leng, Xuefeng; Han, Yongtao; Peng, Lin; Tang, Xiaoli; Wang, Qifeng
分享
收藏Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial
Wu, Lei; Li, Baisen; Wan, Gang; Wang, Yi; Zhu, Jie; Liang, Long; Leng, Xuefeng; He, Wenwu; Peng, Lin; Han, Yongtao; He, Shuya; Wang, Dongsheng; Zhou, Yehan; Yi, Liang; Zhang, Wencheng; Pang, Qingsong; Zhang, Wei; Li, Tao; Lang, Jinyi; Liu, Yang; Cao, Bangrong; Wang, Qifeng
分享
收藏Reduction in chemotherapy relative dose intensity decreases overall survival of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal carcinoma
Jiang, Li; Zhu, Jie; Chen, Xue; Wang, Yi; Wu, Lei; Wan, Gang; Han, Yongtao; Leng, Xuefeng; Zhang, Jun; Peng, Lin; Wang, Qifeng
分享
收藏
分享
收藏Effects of adjunctive Chinese patent medicine on outcome of viral encephalitis in children: A multicenter retrospective study in China
Wang, Peng; Chen, Yang; Wan, Gang; Liu, Huazhang; Liu, Li; Wen, Danning; Yan, Yibin; Wang, Yingyan; Li, Xin; Yang, Qiaozhi; Zhang, Wei
分享
收藏Optimal Time-to-Surgery Recommendations Based on Primary Tumor Volume Regression for Patients with Resectable Esophageal Cancer after Neoadjuvant Chemoradiotherapy: A Retrospective Study新辅助放化疗后可切除食管癌患者基于原发肿瘤体积回归的最佳手术时间建议: 一项回顾性研究
Li, Jingqiu; Zhou, Xiaoding; Liu, Ying; Zhu, Jie; Wan, Gang; Wang, Yi; Leng, Xuefeng; Han, Yongtao; Peng, Lin; Wu, Lei; Wang, Qifeng
分享
收藏EUS-derived maximum tumor thickness and tumor shrinkage rate as independent prognostic factors in locally advanced esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapyEUS衍生的最大肿瘤厚度和肿瘤收缩率是局部晚期食管鳞癌新辅助放化疗后的独立预后因素
Chen, Xue; Chen, Xi; Bao, Yu; Zhang, Wei; Jiang, Li; Zhu, Jie; Wang, Yi; Wu, Lei; Wan, Gang; Peng, Lin; Han, Yongtao; Leng, Xuefeng; Wang, Qifeng; Zhao, Rui
分享
收藏Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study(vol 17, 218, 2022)紫杉醇联合卡铂与紫杉醇联合顺铂在局部晚期食管癌新辅助放化疗中的安全性和有效性: 一项回顾性研究 (第17卷,218,2022)
Jiang, Li; Zhu, Jie; Chen, Xue; Wang, Yi; Wu, Lei; Wan, Gang; Han, Yongtao; Leng, Xuefeng; Peng, Lin; Wang, Qifeng
分享
收藏
分享
收藏Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study紫杉醇联合卡铂与紫杉醇联合顺铂在局部晚期食管癌新辅助放化疗中安全性和有效性的回顾性研究
Jiang, Li; Zhu, Jie; Chen, Xue; Wang, Yi; Wu, Lei; Wan, Gang; Han, Yongtao; Leng, Xuefeng; Peng, Lin; Wang, Qifeng
分享
收藏
分享
收藏Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
He, Wenwu; Wang, Chenghao; Wu, Lei; Wan, Gang; Li, Baisen; Han, Yongtao; Li, Haojun; Leng, Xuefeng; Du, Kunyi; Chen, Haijun; Wang, Qifeng; Peng, Lin
分享
收藏Toripalimab in Combination With Induction Chemotherapy and Subsequent Chemoradiation as First-Line Treatment in Patients With Advanced/Metastatic Esophageal Carcinoma: Protocol for a Single-Arm, Prospective, Open-Label, Phase II Clinical Trial (TR-EAT)
Wu, Lei; Wang, Yi; Li, Baisen; Wan, Gang; Liang, Long; Li, Tao; Lang, Jinyi; Wang, Qifeng
分享
收藏
分享
收藏
分享
收藏The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24) (vol 11, 4839, 2021)
Zhang, Xue-Lian; Yuan, Shen-Yuan; Wan, Gang; Yuan, Ming-Xia; Yang, Guang-Ran; Fu, Han-Jing; Zhu, Liang-Xiang; Zhang, Jian-Dong; Li, Yu-Ling; Gao, Da-yong; Cui, Xue-Li; Wang, Zi-ming; Xie, Rong-Rong; Chen, Ying-jun
分享
收藏